Skip to content
-
Get Breaking News Alerts
Subscribe to SRKANALYTICS.COM Push Notifications and never miss important updates.
SRK Analytics SRK Analytics

Money Roar

  • Home
  • Business Insights
  • Market
  • Startup
  • Emerging Market
  • IPOs
  • Corporate Updates
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

weight loss drugs

  • Home
  • weight loss drugs
FDA Advisory Panel Endorses Broader Peptide Access, Igniting Concerns Over Compounding Pharmacy Boom
Posted inBusiness Insights

FDA Advisory Panel Endorses Broader Peptide Access, Igniting Concerns Over Compounding Pharmacy Boom

A Food and Drug Administration (FDA) advisory panel voted this week to endorse expanded access to therapeutic peptides through compounding pharmacies, a decision that health experts warn could spark an…
Posted by Prasenjit Bhowmik July 25, 2026
Eli Lilly's Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Posted inBusiness Insights

Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle

Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
Posted by Prasenjit Bhowmik July 23, 2026

Recent Posts

  • Finolex Cables and Three Other Stocks Flash Bullish Signals
  • Deepa Jewellers IPO Allotment Status Set For Finalization Today
  • Gland Pharma Shares in Focus as Promoter Fosun Plans Major Stake Sale
  • Qualiance International SME IPO Opens: Key Details and Growth Outlook
  • Anant Raj and Nifty 500 Stocks Exhibit Bullish RSI Momentum

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026

Categories

  • Business Insights
  • Corporate Updates
  • Economy
  • Emerging Market
  • Market
  • Startup
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Aug    
Copyright 2026 — SRK Analytics. All rights reserved.
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Contact Us
  • About Us
Scroll to Top
Follow by Email
Facebook
fb-share-icon
X (Twitter)
Post on X
LinkedIn
Share
Instagram
Telegram
WhatsApp
THREADS

Website security powered by MilesWeb